Infertility
Conditions
Interventions
None listed
Sponsors
Igenomix Foundation
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patients whose written informed consent approved by the Ethics Committee has been obtained, after having been duly informed of the nature of the study and voluntarily accepted to participate after being fully aware of the potential risks, benefits and any discomfort involved. Infertile patients between 18-37 years old with positive diagnose of CE by EMMA test already performed in an HRT cycle (P+5 day,120+-3h of progesterone exposure). IVF patients with own oocytes aged 18-37 years old. BMI, 18.5 to 30.0 (both inclusive). Negative serological tests for HIV, HBV, HCV, RPR. Sperm concentration is more than 2 million sperm/ml
Exclusion criteria
Exclusion criteria: Patients who are IUD carriers in the 3 months prior to the first biopsy for EMMA test. Patients who have taken prescribed antibiotics in the last 3 months prior to the first biopsy for EMMA test. Cases where the patient has received previous prophylactic antibiotics (1 single dose) to ovarian puncture in the stimulation cycle may be accepted. The administration of this prophylactic antibiotic should be at least 1 month before the sample collection (first biopsy for the EMMA test). Patients that received any surgical procedure in the 3 months prior to the first biopsy for EMMA test. Patients that present a different endometrial preparation (HRT) for the different cycles included in the study (1st mock cycle, 2nd mock cycle, ET cycle) in terms of P4 dosage, timing or route of administration. Patients with endogenous P4 >1ng/mL determined at day P+0 of the HRT cycles included in the study (1st mock cycle, 2nd mock cycle, ET cycle) or with unknow levels of endogenous P4 before the administration exogenous progesterone in any of the HRT cycles included in the study. Patients receiving personalized ET with embryos other than blastocyst in days 5 or 6. Patients cured of CE that do not follow the recommendations of the 2nd ERA test for pET. And others.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Result of the ERA test | — |
Countries
Japan,Europe
Contacts
Public ContactInmaculada Moreno
Igenomix Foundation Igenomix Foundation
Outcome results
None listed